Análisis de la acción Waldencast PLC (WALD)WALDWaldencast PLC

Waldencast plc is a global multi-brand beauty and wellness platform. It is focused on developing, acquiring, accelerating, and scaling conscious and purpose-driven brands. Its segments include Obagi Medical and Milk Makeup. The Obagi Medical segment sells advanced skincare products backed by science and formulated to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines and wrinkles, and to protect and enhance skin tone and texture. Its portfolio of medical-grade skincare with consumer-centric, in-office injectable procedures includes Saypha ChIQ, and MagIQ lines of injectable hyaluronic acid gels. The Milk Makeup segment consists of the business of Milk. Its Milk’s business activities include developing, marketing, and selling cosmetics, skincare, and other beauty products. Its Milk Makeup segment offers over 250 products through its United States Website www.MilkMakeup.com and retail partners include Sephora globally and Ulta Beauty in the United States. It operates in the Consumer Cyclicals sector (PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS industry).

Waldencast PLC is currently not a strong buy due to its recent financial performance and analyst downgrades, despite some positive catalysts. The stock is trading at $1.34, with a forward P/E of 45.045, suggesting high expectations for future earnings. However, the company reported a Q4 net loss of $33.5 million and has seen a significant decline in its stock price, down 21.64% year-to-date. The main risk is the ongoing strategic review and disappointing sales performance, particularly in the Milk Makeup brand, which could hinder recovery.